Peru

Peru legalized medical cannabis and its derivatives in 2017 via Law 30681. DIGEMID (General Directorate of Drugs) oversees product registration and licensing. The implementing regulations were finalized in 2019, allowing licensed production, import, and commercialization of cannabis products.

Ask the Expert about Peru

Regulator

DIGEMID

Key Legislation

Law 30681

Year Legalized

2017

Program Size

Early implementation; growing patient...

Key Facts

Law 30681 authorizes production, import, and commercialization for medical and therapeutic use
Implementing regulations (Supreme Decree 005-2019-SA) were issued in February 2019
DIGEMID manages product registration and quality standards
Personal cultivation is not authorized; patients must use licensed products
Several Peruvian companies have received cultivation and production licenses

Key Legislation

Law 30681 (November 2017)

Regulatory Body

DIGEMID (General Directorate of Drugs, Supplies and Medicines)

Country Info

ISO Code

Region

South America

Tier

Tier 2 — Emerging

Status

Emerging Program

Sources

DIGEMID

Disclaimer: This information is for general reference only and does not constitute legal advice. Cannabis regulations change frequently. Always verify with official sources and local legal counsel before making compliance decisions.